NI
GILD icon

Nepsis Inc’s Gilead Sciences GILD Stock Holding History

Nepsis Inc’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-36,308
Closed -$3.33M – 41
2016
Q1 		$3.33M Sell
36,308
-31,675
-47% -$2.86M 1.79% 31
2015
Q4 		$6.88M Sell
67,983
-3,826
-5% -$398K 3.99% 10
2015
Q3 		$7.05M Buy
71,809
+7,001
+11% +$778K 4.2% 10
2015
Q2 		$7.46M Buy
64,808
+24,474
+61% +$2.67M 5.02% 7
2015
Q1 		$3.96M Buy
+40,334
New +$4.1M 2.39% 24

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nepsis Inc's GILD Position: Q2 2016 in Review

Nepsis Inc sold out of Gilead Sciences (GILD) in Q2 2016, closing a stake of 36,308 shares — an estimated $3.33M sold.

Nepsis Inc first reported a position in GILD in Q1 2015 and held it in 5 quarters. The position peaked at $7.46M in Q2 2015. 1,597 funds tracked by Wall St. Rank hold GILD as of Q2 2016.

  • Nepsis Inc reported no remaining Gilead Sciences position as of Q2 2016 after selling out during the quarter.
  • Nepsis Inc sold 36,308 Gilead Sciences shares in Q2 2016, an estimated $3.33M.
  • Nepsis Inc first reported a position in Gilead Sciences in Q1 2015 and held it in 5 quarters.
  • Nepsis Inc's Gilead Sciences position peaked at $7.46M in Q2 2015.
  • 1,597 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2016.

Based on Nepsis Inc's 13F filing for Q2 2016, filed 12 Jul 2016.